David E. Gloriam



David Gloriam started his research career at Uppsala University where he in 2006 received a PhD degree for the bioinformatic discovery of 24 human receptors and the overall receptor repertoires in dog, mouse, rat and chicken. In 2006-7, he was at the EMBL – Bioinformatics Institute where he developed a global protein informatics standard and data exchange format for protein affinity reagents. In 2007-2008, he made another postdoc at GlaxoSmithKline where he conducted computational drug design and developed chemogenomic methods for ligand/drug discovery. Since late 2008, he has been at the Department of Drug Design and Pharmacology at the University of Copenhagen where he has expanded his research to scientific database development, data science and experimental structural biology. In 2019, he became the leader of a Departmental Cluster for GPCR Function and Drug Discovery and in 2020 he also became affiliated with a Faculty Center for Health Data Science

© All rights reserved, Sciencenews 2020